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The commensal bacteria found in the human gut are important for host health, and an unfavorable 
composition of the gut microbiota can affect the synergistic interaction that exists between microbes and 
their host. An altered microbial composition is suggested to play a pivotal role in the pathogenesis of 
ulcerative colitis (UC), an inflammatory bowel disease, and compositional changes have been observed in 
the colonic microbiota by us as well as by other research groups 1-3. Since bifidobacteria and lactobacilli 
may excert anti-inflammatory effects, a reduced level of these commensal bacteria may compromise the 
colon health and favor intestinal inflammation.  
In this study, selective stimulation of fecal bifidobacteria and lactobacilli from healthy subjects and UC 
patients in remission or with active disease were investigated using arabino-oligosaccharides (AOS; DP2-10) 
derived from sugar beet pulp. The fermentative-induced changes were compared to those for fructo-
oligosaccharides (FOS), which are known to have a prebiotic effect. The fermentation studies were carried 
out using a validated small-scale static batch system, and changes in the fecal microbial communities and 
metabolites were monitored after 24 h by quantitative real-time PCR and short-chain fatty acid analysis. 
With a few minor exceptions, AOS affected the communities similarly to what was seen for FOS. 
Quantitative real-time PCR revealed that Bifidobacterium spp. and Lactobacillus spp. were selectively 
increased after fermentation of AOS or FOS by fecal microbiota derived from UC patients. The stimulation 
of growth of Lactobacillus spp. and Bifidobacterium spp. was accompanied by a high production of acetate 
and hence a decrease of pH. The fermentation of AOS may thus help improve the inflammatory conditions 
in UC patients through stimulation of bacteria eliciting anti-inflammatory responses and through 
production of acetate.  
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